GERONTOLOGICAL PHYSIOTHERAPY IN FALLS PREVENTION AND PREHABILITATION
With
Dr Rik Dawson,
Gerontological Physiotherapist &
Postdoctoral Researcher,
Institute for Musculoskeletal Health, University of Sydney &
National President, Australian Physiotherapy Association
RESEARCHER PROFILE
Filmed in Sydney, Australia | August 2026
Dr Rik Dawson is a gerontological physiotherapist and health leader dedicated to improving healthy ageing through evidence-based physiotherapy, digital health and health system reform. As a Postdoctoral Researcher at the Institute for Musculoskeletal Health, University of Sydney, and President of the Australian Physiotherapy Association, he combines research and policy to improve access to high quality care for older people.
With more than 30 years of experience across clinical practice Dr Dawson founded Agewell Physiotherapy, growing it into one of Australia’s largest aged care physiotherapy providers before selling the business in 2020. He now leads TOP UP Therapy, a digital health company translating his PhD research into practice through an evidence-based strength and balance exercise platform that demonstrated that physiotherapist led telehealth exercise can improve mobility, reduce falls and help older people remain independent.
Dr Dawson provides national leadership in aged care, workforce and primary care reform and serves on several Australian Government advisory committees, including the Strengthening Medicare Implementation Oversight Committee. He is also a member of Falls Prevention Alliance Australia and the Australian Cardiovascular Alliance. His research has attracted funding from the Medical Research Future Fund, ARIIA, Dementia Australia and the Global Alliance for Chronic Diseases, with collaborations across Australia and Brazil.
Outside work, Dr Dawson is a trained opera singer with a Bachelor of Creative Arts, a certified yoga instructor and a regular volunteer leading singalongs in residential aged care. He is married to a physiotherapist, has a daughter who is a physiotherapist and a son studying psychology.
Source: Supplied
https://orcid.org/0000-0001-9652-4711
-
Role of Community Paramedicine in Non-Emergency Presentations
Dr Robbie King is a Lecturer in paramedicine and researcher at the Australian Catholic University (ACU) Brisbane. He also continues to provide clinical care as a registered paramedic for community members served by a jurisdictional ambulance service. Dr King has gained significant experience working in an advanced practice, community paramedic style role, holding expert clinical insight into the nuances of paramedic-led community-based healthcare for non-emergency presentations. This often involves adopting a biopsychosocial approach, rather than following the biomedical model more associated with emergency medicine and paramedic culture.
-
Novel therapies & next-gen medical devices in cardiovascular & vascular disease management
Professor Shirley Jansen AM is a distinguished vascular and endovascular surgeon whose career spans clinical leadership, academic excellence, and pioneering research. She currently holds the Lawrence-Brown Chair of Vascular Surgery at Curtin University’s School of Population Health and serves as Head of the Department of Vascular Surgery at Sir Charles Gairdner Hospital, a role she has held since 2015. In addition, she is the Director of the Heart & Vascular Research Institute at the Harry Perkins Institute for Medical Research. Her early career was marked by prestigious fellowships, including a British Heart Foundation Research Fellowship (1996), and multiple international travelling fellowships from leading surgical societies and industry sponsors between 2001 and 2002.
-
Next-generation NK cell-based immunotherapies for hard-to-treat cancers
Associate Professor Fernando Guimaraes is an internationally recognised leader in cancer immunotherapy and natural killer (NK) cell biology. Based at The University of Queensland, he leads innovative research focused on developing next-generation NK cell-based immunotherapies for hard-to-treat cancers, including sarcomas and neuroblastoma.
